Evidence map›Paper›PMID 24968183›Full record

ArticleAmerican journal of health promotion : AJHP

Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.

Clement K Gwede, Stacy N Davis, Shaenelle Wilson, Mitul Patel, Susan T Vadaparampil, Cathy D Meade, Brian M Rivers, Daohai Yu, Javier Torres-Roca, Randy Heysek and 3 more

Abstract read
In one paragraph

Article in American journal of health promotion : AJHP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Article
  6. Article
  7. Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2017
    Article
  8. What's new in screening in 2015?Current opinion in urology · 2016
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Clement K Gwede
Stacy N Davis
Shaenelle Wilson
Mitul Patel
Susan T Vadaparampil
Cathy D Meade
Brian M Rivers
Daohai Yu
Javier Torres-Roca
Randy Heysek
Philippe E Spiess
Julio Pow-Sang
Paul Jacobsen

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Behavioral Oncology Education & Career DevelopmentR25CA090314 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI BRANDON, THOMAS H · 2003 to 2018
$4.0M
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer PatientsR21CA125428 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GWEDE, CLEMENT K. · 2008 to 2009
$674k
NCI NIH HHS 1R21 CA125428NCI NIH HHS P30 CA076292NCI NIH HHS R21 CA125428NCI NIH HHS R25 CA090314
6 · The paper itself

Abstract

purposeFirst-degree relatives (FDRs) of prostate cancer (PC) patients should consider multiple concurrent personal risk factors when engaging in informed decision making (IDM) about PC screening. This study assessed perceptions of IDM recommendations and risk-appropriate strategies for IDM among FDRs of varied race/ethnicity.

designA cross-sectional, qualitative study design was used.

settingStudy setting was a cancer center in southwest Florida.

participantsThe study comprised 44 participants (24 PC patients and 20 unaffected FDRs).

methodFocus groups and individual interviews were conducted and analyzed using content analysis and constant comparison methods.

resultsPatients and FDRs found the PC screening debate and IDM recommendations to be complex and counterintuitive. They overwhelmingly believed screening saves lives and does not have associated harms. There was a strongly expressed need to improve communication between patients and FDRs. A single decision aid that addresses the needs of all FDRs, rather than one separating by race/ethnicity, was recommended as sufficient by study participants. These perspectives guided the development of an innovative decision aid that deconstructs the screening controversy and IDM processes into simpler concepts and provides step-by-step strategies for FDRs to engage in IDM.

conclusionImplementing IDM among FDRs is challenging because the IDM paradigm departs from historical messages promoting routine screening. These contradictions should be recognized and addressed for men to participate effectively in IDM. A randomized pilot study evaluating outcomes of the resulting decision aid is underway.

Indexed as

Conflict, PsychologicalDecision Support TechniquesEarly Detection of CancerFamilyHealth Knowledge, Attitudes, PracticeAdultAgedAged, 80 and overCross-Sectional StudiesDecision MakingFloridaFocus GroupsHumansMaleMass ScreeningMiddle AgedDecision AidFamily HistoryFirst-Degree RelativesHealth focus: social healthHealth PromotionInformed Decision MakingManuscript format: researchOutcome measure: behavioralPrevention ResearchProstate CancerResearch purpose: descriptiveSetting: clinical/health careStrategy: education, skill building/behavior change, and culture changeStudy design: qualitativeTarget population age: adultsTarget population circumstances: race/ethnicity and male first-degree relatives

Identifiers

PMID24968183
PMCPMC4277494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.